Study of effects of vitamin D on some genes expression in multiple sclerosis patients
Not Applicable
- Conditions
- Multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT2014081818840N1
- Lead Sponsor
- Vice Chancellor forTarbiat Modares University of Tehran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
relapsing-remitting multiple sclerosis patients; MS patients with vitamin D deficiency (<80ng/ml). Exclusion criteria: patients treated with vitamin D supplements; progressive MS; relapsed patients, psychiatric patients and the patients who are taken steroid drugs.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Expression of IL2 gene. Timepoint: before vitamin D treatment and two month after treatment. Method of measurement: taking of blood from patients and measurment of mRNA level.
- Secondary Outcome Measures
Name Time Method Expression of IL4 ,IL6,IL17A,CYP27A1 and CYP27B1. Timepoint: before vitamin D treatment and two month after treatment. Method of measurement: taking of blood from patients and measurement of mRNA level.